Research Reports Coverage on Application Software Stocks — Twilio, Allscripts Healthcare Solutions, Tableau Software, and MuleSoft

NEW YORK, May 15, 2017 /PRNewswire/ —

On Friday, the NASDAQ Composite ended the day at 6,121.23, up 0.09%; the Dow Jones Industrial Average edged 0.11% lower, to finish at 20,896.61; and the S&P 500 closed at 2,390.90, slightly slipping 0.15%. Gains were broad based as five out of nine sectors finished the trading session in green. has initiated research reports on the following Application Software stocks: Twilio (NYSE: TWLO), Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX), Tableau Software Inc. (NYSE: DATA), and MuleSoft Inc. (NYSE: MULE). Learn more about these stocks by downloading their comprehensive and free reports at:


San Francisco, California headquartered Twilio’s shares finished Friday’s session 3.00% higher at $24.00. A total volume of 4.43 million shares was traded, which was above their three months average volume of 3.47 million shares. The stock is trading below its 50-day moving average by 18.64%. Moreover, shares of Twilio, which provides cloud communications platform that enables developers to build, scale, and operate communications within software applications through the cloud as a pay-as-you-go service in the US and internationally, have a Relative Strength Index (RSI) of 31.56.

On May 03rd, 2017, research firm Pacific Crest downgraded the Company’s stock rating from ‘Overweight’ to ‘Sector Weight’. TWLO complete research report is just a click away and free at:

Allscripts Healthcare Solutions  

Shares in Chicago, Illinois headquartered Allscripts Healthcare Solutions Inc. ended the day 2.53% lower at $12.32, with a total trading volume of 1.89 million shares. The stock has advanced 0.49% in the last month, 3.62% in the previous three months, and 20.67% since the start of this year. The Company’s shares are trading 1.49% and 2.00% above their 50-day and 200-day moving averages, respectively. Moreover, shares of Allscripts Healthcare Solutions, which provides information technology and services to healthcare organizations in the US, Canada, and internationally, have an RSI of 53.74. The complimentary report on MDRX can be downloaded at:

Tableau Software  

Seattle, Washington headquartered Tableau Software Inc.’s stock rose 0.68%, closing the session at $60.72. A total volume of 632,595 shares was traded. The Company’s shares have gained 19.39% in the last one month, 12.95% in the previous three months, and 44.06% on an YTD basis. The stock is trading 17.02% above its 50-day moving average and 19.82% above its 200-day moving average. Additionally, shares of Tableau Software, which provides business analytics software products, have an RSI of 84.83.

On May 04th, 2017, research firm BMO Capital Markets reiterated its ‘Outperform’ rating on the Company’s stock with an increase of the target price from $55 a share to $64 a share. Sign up for your complimentary research report on DATA at:


On Friday, shares in San Francisco, California headquartered MuleSoft Inc. finished the session 1.12% lower at $22.00. A total volume of 356,526 shares was traded. Shares of the Company, which owns and operates Anypoint Platform, an integration solution for connecting applications, data sources, and devices, both on-premises and in the cloud, are trading below its 50-day moving average by 4.07%. Get free access to your research report on MULE at:

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If youre a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA